On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
On Jun. 23, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 23, 2020, FibroGen announced the initiation of a randomized, double-blind, placebo-controlled Phase 2 Study investigating the…
On Jun. 23, 2020, studies in the Netherlands and other places have shown that the presence of SARS-Coronavirus-2,…
On Jun. 22, 2020, Catalent announced that it had signed an agreement with ViralClear Pharmaceuticals, a subsidiary of…
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…
On Jun. 20, 2020, the National Institutes of Health (NIH) announced that a clinical trial to evaluate the…
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
On Jun. 18, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine, in collaboration with…
On Jun. 17, 2020, Innovation Pharma reported receiving data from ongoing laboratory testing being conducted at a U.S….
On Jun. 16, 2020, a consortium that includes many of San Diego’s top medical and scientific research institutes…
On Jun. 15, 2020, the NIH announced it had launched a centralized, secure enclave to store and study…
On Jun. 15, 2020, a team led by Scripps Research discovered antibodies in the blood of recovered COVID-19…
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
On Jun. 12, 2020, a tiny genetic mutation in the SARS coronavirus 2 variant circulating throughout Europe and…
On Jun. 12, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $349,999 to Dr. Vaithilingaraja Arumugaswami at…
On Jun. 12, 2020, Cue Health announced that it had received Emergency Use Authorization from the U.S. Food…
On Jun. 12, 2020, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Tivicay (dolutegravir) tablets and…
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Jun. 11, 2020, Atossa Therapeutics announced that the manuscript of the results from in vitro testing of…
On Jun. 11, 2020, a team of researchers from the National Library of Medicine identified genomic features of…
On Jun. 11, 2020, scientists announced the development of a new test that can help identify people who…
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
On Jun. 11, 2020, Innovation Pharma announced the Company and researchers at a U.S. Regional Biocontainment Laboratory (RBL)…
On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
On Jun. 10, 2020, the FDA issued an emergency use authorization (EUA) to Illumina for the first COVID-19…
On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…